PSMA-617 Lu-177
2-[4-[2-[[4-[[(2S)-1-[[(5S)-5-carboxy-5-[[(1S)-1,3-dicarboxypropyl]carbamoylamino]pentyl]amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]carbamoyl]cyclohexyl]methylamino]-2-oxoethyl]-7,10-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;lutetium-177(3+)
Molecular Identity
PSMA-617 Lu-177
2-[4-[2-[[4-[[(2S)-1-[[(5S)-5-carboxy-5-[[(1S)-1,3-dicarboxypropyl]carbamoylamino]pentyl]amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]carbamoyl]cyclohexyl]methylamino]-2-oxoethyl]-7,10-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;lutetium-177(3+)
PubChem CID: 122706785
2D Structure
Properties
C49H68LuN9O16
Molecular Formula
1216.10
Molecular Weight
g/mol
1215.4222
Exact Mass
Da
374
TPSA
May have limited oral absorption
8
H-Bond Donors
20
H-Bond Acceptors
1860
Complexity
SMILES
Canonical SMILES
SMILES: C1CC(CCC1CNC(=O)CN2CCN(CCN(CCN(CC2)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])C(=O)NC(CC3=CC4=CC=CC=C4C=C3)C(=O)NCCCCC(C(=O)O)NC(=O)NC(CCC(=O)O)C(=O)O.[Lu+3]Isomeric SMILES
SMILES: C1CC(CCC1CNC(=O)CN2CCN(CCN(CCN(CC2)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])C(=O)N[C@@H](CC3=CC4=CC=CC=C4C=C3)C(=O)NCCCC[C@@H](C(=O)O)NC(=O)N[C@@H](CCC(=O)O)C(=O)O.[177Lu+3]Synonyms(20)
G6UF363ECXLutetium Lu-177 vipivotide tetraxetan177Lu-Psma-617Vipivotide tetraxetan Lu-177177Lu-Labeled PSMA-617PSMA-617 Lu-177UNII-G6UF363ECXVipivotide tetraxetan lutetium Lu-177Lutetium (177Lu) vipivotide tetraxetanlutetium lu 177 vipivotide tetraxetan [USAN]WHO 114291703749-62-5PLUVICTOSCHEMBL29361946Lutetium (177Lu) vipivotide tetraxetan [MI]
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to PSMA-617 Lu-177
Loading drug network...